Predictive Value of the DD4 Questionnaire on Depressive Relapse After Hospitalization

NCT ID: NCT05678907

Last Updated: 2024-07-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-02

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, longitudinal, single-center observational study of data from the medical records of patients hospitalized after a characterized depressive episode and reviewed three months after hospital discharge, as part of a normally scheduled evaluation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients in the study were hospitalized following a characterized depressive episode. The study is based on a review of these patients' medical records and data from the three-month assessment. No additional assessments are planned.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depressive Episode

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient 18 years of age or older, having been informed of the research
* Patient hospitalized at the Auzon Clinic for a characterized depressive episodé (isolated episode or recurrent depressive disorder)
* Discharged from hospitalization
* Considered in remission (total or partial) and with a MADRS score \< 20

Exclusion Criteria

* Patient hospitalized for \< 15 days
* Patient with bipolar depression
* Patient with a psychotic disorder
* Patient using narcotics with a "moderate to severe" severity
* Patient previously included in this study
* Patient under court protection, guardianship or curatorship
* Patient unablé to respond correctly to a depression self-assessment questionnaire
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique de l'Auzon

La Roche-Blanche, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Anne-Marie TRONCHE, MD

Role: primary

04 73 79 84 46 ext. 33

Jean-Luc DUCHER, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

COS-RGDS-2022-06-054

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Rhythm and Depression
NCT02857036 UNKNOWN NA